Dermata Therapeutics, Inc. Common Stock (NASDAQ: DRMA) last traded at $0.861, down 3.24% on the session. The quote above updates while this page is open; the figures below are drawn from Dermata Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Dermata Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DRMA. Its market capitalisation is $3.46 million.
Valuation measures for Dermata Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.46M |
|---|---|
| Enterprise value | $882.6K |
| Price / book | 0.99 |
| Beta | 0.96 |
Trailing-twelve-month figures tagged in Dermata Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$8.37M |
| Return on equity | -239.95% |
|---|
| Cash | $4.41M |
|---|
Range and volume for DRMA over the past 52 weeks.
| 52-week high | $4.66 |
|---|---|
| 52-week low | $0.861 |
| Volume | 23.4K |
| Average volume | 685.3K |
| Previous close | $0.890 |
Invest a chosen dollar amount in Dermata Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DRMA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.